Nucleic acid encoding a Brain Derived Tau Kinase polypeptide and methods of use thereof
AssigneeBoard of Regents of the University of Nebraska
InventorTsuneya Ikezu
Life of this patent
Estimating the term…
Abstract
The present invention provides materials and methods for treating Alzheimer's disease and other tau related neurodegenerative disorders. A tau kinase, Brain Derived Tau Kinase (BDTK) is provided. BDTK can cause hyperphosphorylation of tau protein, which leads to formation of neurofibrillary tangles, which are implicated in the degenerative symptoms of Alzheimer's and other neurodegenerative disorders. Methods of diagnosis and treatment based on the discovery of this novel tau kinase are also provided.
Claims8
An isolated nucleic acid molecule comprising a sequence encoding a Brain Derived Tau Kinase (BDTK) protein, said BDTK protein having the amino acid sequence of SEQ ID NO:
- 2, wherein said nucleic acid molecule is a cDNA that encodes said BDTK protein.
An isolated nucleic acid molecule comprising a sequence encoding a Brain Derived Tau Kinase (BDTK) protein, said BDTK protein having the amino acid sequence of SEQ ID NO:
- 2, wherein said nucleic acid molecule is RNA.
An isolated nucleic acid molecule encoding a polypeptide, which is a fragment of SEQ ID NO:2, wherein the encoded polypeptide consists of the amino acid sequence of SEQ ID NO:3.
An isolated nucleic acid molecule comprising a sequence selected from the group consisting of:
- a) SEQ ID NO:
- 1;
- b) a sequence which is the complete complement of SEQ ID NO:
- 1;
- and
- c) a nucleic acid sequence encoding a polypeptide which is a fragment of a Brain Derived Tau Kinase (BDTK) protein of SEQ ID NO:
- 2, wherein the amino acid sequence of said polypeptide is amino acids 33-290 of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.